Bausch Health Companies Inc. (BHC)

NYSE: BHC · USD

$6.92

+0.61 (+9.7%)· Recorded snapshot

Market cap	2.6B
Revenue (ttm)	10.9B
Net income (ttm)	-1.1B
EPS (ttm)	-$2.95
Shares out	374M
P/E (forward)	1.4x
Volume	6,369,934
Beta	0.37

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 10.9B
Net income (ttm): -1.1B
EPS (ttm): -$2.95
P/E (forward): 1.4x
Market cap: 2.6B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E1.4

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC13.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BHC indicators

Market & fundamental data

Available fields

250

Groups with data

Currency

USD

Showing 250 of 250 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000885590
Company name	Bausch Health Companies Inc.
Country	Canada
Country code	US
CUSIP number	071734107
Earnings date	2026-10-28
Earnings time	amc
Employees	20,300
Employees change	-400
Employees growth	-1.93%
Enterprise value	$21.5B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
Is SPAC	No
ISIN number	CA0717341071
Last 10-K release date	2026-02-19
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Last stock split date	2000-10-05
Last stock split type	Forward
Market cap	$2.6B
Market cap category	Mid-Cap
Next earnings date	2027-02-04
Options	Yes
Price	$6.92
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	BHC
Website	https://www.bauschhealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	1.61x
Earnings yield	-42.6%
EV/EBIT	7.87x
EV/EBITDA	5.51x
EV/FCF	15.05x
EV/Sales	1.98x
FCF / EV yield	6.64%
FCF yield	55.29%
Forward EV/Sales	1.98x
Forward P/E	1.43x
Forward P/S	0.24x
Industry forward P/E	13.87x
Industry P/E	173.94x
P/(FCF - SBC) ratio	2.16x
P/(OCF - SBC) ratio	1.65x
P/FCF ratio	1.81x
P/OCF ratio	1.44x
P/S ratio	0.24x
Price/EBITDA ratio	0.66x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	25.21%
EBITDA margin	36.01%
FCF margin	13.19%
Gross margin	71.82%
Operating margin	25.21%
Pretax margin	-6.74%
Profit margin	-10.12%
Profit per employee	$-54,089
Profitable quarters	1
Profitable years	1
Revenue per employee	$534,631
ROA	6.57%
ROA (5Y)	4.05%
ROCE	13.51%
ROIC	13.61%
ROIC (5Y)	4.19%
SBC / revenue	2.15%
Tax / revenue	3.33%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth (Q)	70.41%
EPS growth quarters	1
EPS growth years	2
FCF growth	28.34%
FCF growth (Q)	212.11%
FCF growth (QoQ)	390.08%
FCF growth 5Y	3.6%
Gross profit growth	11.84%
Gross profit growth (Q)	17.78%
Gross profit growth 3Y	9.83%
Gross profit growth 5Y	5.17%
Net income growth (Q)	74.32%
Net income growth quarters	1
Net income growth years	2
OCF growth	19.52%
OCF growth (Q)	131.83%
OCF growth (QoQ)	191.3%
OCF growth 10Y	-2.67%
OCF growth 5Y	3.88%
Operating income growth	43.85%
Operating income growth (Q)	69.58%
Operating income growth 3Y	23.83%
Operating income growth 5Y	10.06%
Revenue growth	10.09%
Revenue growth (Q)	12.73%
Revenue growth (QoQ)	13%
Revenue growth 10Y	0.49%
Revenue growth 3Y	9.13%
Revenue growth 5Y	5.06%
Revenue growth quarters	14
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-369M
Depreciation and amortization	$1.2B
EBIT	$2.7B
EBITDA	$3.9B
EPS	$-2.95
FCF per share	$3.83
Financing cash flow	$-1.1B
Free cash flow	$1.4B
Free cash flow minus SBC	$1.2B
Gross profit	$7.8B
Income taxes	$361M
Investing cash flow	$-597M
Net borrowing	$-1B
Net cash flow	$95M
Net income	$-1.1B
Operating cash flow minus SBC	$1.6B
Operating income	$2.7B
Revenue	$10.9B
Stock-based compensation	$233M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.34
Book value per share	$-4.74
Debt / EBITDA	5.18
Debt / FCF	14.52
Goodwill	$9.8B
Interest coverage	1.7
Long-term assets	$18.3B
Long-term liabilities	$21.1B
Net cash (debt)	$-19B
Net cash / market cap	-732.38%
Net debt / EBITDA	4.85
Net debt / FCF	13.25
Piotroski F-Score	7
Property, plant and equipment	$2.1B
Shareholders' equity	$-802M
Tangible book value	$-15.7B
Tangible book value per share	$-42.10
Total assets	$24.8B
Total cash	$1.8B
Total debt	$20.8B
Total liabilities	$25.6B
WACC	6.13%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.42
Current assets	$6.5B
Current liabilities	$4.5B
Current ratio	1.44
Inventory turnover	1.88
Net working capital	$1B
Quick ratio	0.9
Working capital	$2B
Working capital turnover	6.17

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.45%
Dividend growth (3Y)	-13.82%
Dividend per share	$0.00
Dividend yield	0%
Last dividend	$1.00
Shareholder yield	-0.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-69.52%
10Y return CAGR	-11.21%
10Y total return	-69.52%
150-day SMA	$5.64
15Y price change	-83.49%
15Y return CAGR	-11.31%
15Y total return	-83.49%
1D price change	9.67%
1M price change	18.37%
1M total return	18.37%
1W price change	4.91%
1W total return	4.91%
1Y price change	8.63%
1Y return CAGR	8.64%
1Y total return	8.63%
20-day SMA	$6.18
200-day SMA	$5.69
20Y price change	-57.48%
20Y return CAGR	-2.45%
20Y total return	-39.07%
3M price change	50.34%
3M total return	50.34%
3Y price change	2.51%
3Y return CAGR	0.83%
3Y total return	2.51%
50-day SMA	$6.16
50-day SMA vs 200-day SMA	50over200
52-week high	$8.00
52-week high date	2026-01-07
52-week low	$4.33
52-week low date	2026-07-21
5Y price change	-75.74%
5Y return CAGR	-24.67%
5Y total return	-75.74%
6M price change	20.7%
6M total return	20.7%
All-time high	$263.81
All-time high date	2015-08-06
All-time low	$0.33
All-time low date	1994-04-21
Average true range (ATR)	$0.26
Average volume	2.1M
Beta (1Y)	1.29
Beta (2Y)	0.81
Beta (5Y)	0.37
Change from 52-week high	-13.5%
Change from 52-week low	59.82%
Change from all-time high	-97.45%
Change from all-time low	1,922.52%
Change from open	8.12%
Day's gap	1.43%
Dollar volume	$44.1M
High price	$6.93
Low price	$6.40
Monthly RSI	49.72
Open price	$6.40
Position in 52-week range	98.11%
Premarket change	-0.63%
Premarket close	$6.31
Premarket price	$6.27
Previous close	$6.31
Price vs 150-day SMA	19.41%
Price vs 20-day SMA	9.07%
Price vs 200-day SMA	18.41%
Price vs 50-day SMA	9.26%
Relative volume	3.06
RSI	69.05
Sharpe ratio	0.34
Sharpe ratio (3Y)	0.16
Sharpe ratio (5Y)	-0.2
Sortino ratio	0.72
Sortino ratio (3Y)	0.35
Sortino ratio (5Y)	-0.2
Volume	6.4M
Weekly RSI	59.86
YTD price change	-3.09%
YTD total return	-3.09%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	260.6M
Float percentage	69.67%
Shares change (QoQ)	1.42%
Shares change (YoY)	0.45%
Shares held by insiders	10.73%
Shares held by institutions	36.78%
Shares outstanding	374M
Short % of float	3.23%
Short % of shares	2.25%
Short ratio	3.7 days

Deeper analysis on BHC

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BHC report

Is a complete BHC research report available?

No complete published report is available for Bausch Health Companies Inc. (BHC) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Bausch Health Companies Inc. (BHC)

Price

Financial snapshot

Fair-value bridge

Latest news · BHC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BHC indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BHC

Frequently asked questions